Cargando…

Clinical Impact of JAK2V617F Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms

OBJECTIVE: The impact of JAK2V617F allele burden on clinical course in Philadelphia-negative (Ph-negative) myeloproliferative neoplasms (MPNs) is not clear. We analyzed the clinical impact of JAK2V617F allele burden in a relatively large series of patients with Ph-negative MPNs and long-term follow-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yönal-Hindilerden, İpek, Şahin, Ezgi, Hindilerden, Fehmi, Dağlar-Aday, Aynur, Nalçacı, Meliha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476250/ https://www.ncbi.nlm.nih.gov/pubmed/37584526 http://dx.doi.org/10.4274/tjh.galenos.2023.2023.0169

Ejemplares similares

Prognostic significance of ASXL1, JAK2V617F mutations and JAK2V617F allele burden in Philadelphia-negative myeloproliferative neoplasms
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2015)

Effects of Mutational Combinations on Philadelphia-Negative Myeloproliferative Neoplasms
por: Ipek, Yonal-Hindilerden, et al.
Publicado: (2017)

The Burden of JAK2V617F Mutated Allele in Turkish Patients With Myeloproliferative Neoplasms
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2015)

The Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2016)

Hairy cell leukemia followed by polycythemia vera: report of the first case
por: Ipek, Yonal-Hindilerden, et al.
Publicado: (2016)

MALT lymphoma of the left biceps muscle: a rare case with an interesting presentation
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2016)

Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis
por: Yönal, İpek, et al.
Publicado: (2016)

Primary Mediastinal Large B-Cell Lymphoma As an Incidental Finding: Report of a Case
por: Yönal-Hindilerden, İpek, et al.
Publicado: (2018)

Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases
por: Hindilerden, Fehmi, et al.
Publicado: (2017)

Comparison of Response to Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia According to the Presence of Accessory Spleen
por: Hindilerden, Fehmi, et al.
Publicado: (2022)

Hairy Cell Leukemia Presenting with Isolated Skeletal Involvement Successfully Treated by Radiation Therapy and Cladribine: A Case Report and Review of the Literature
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2015)

Primary B-Cell Mucosa-Associated Lymphoid Tissue Lymphoma of the Hard Palate and Parotid Gland: Report of One Case and Review of the Literature
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2016)

Aleukemic Leukemia Cutis Manifesting with Disseminated Nodular Eruptions and a Plaque Preceding Acute Monocytic Leukemia: A Case Report
por: Yonal, Ipek, et al.
Publicado: (2011)

Relationship of JAK2 (V617F) Allelic Burden with Clinico-Haematological Manifestations of Philadelphia-Negative Myeloproliferative Neoplasms
por: Yow, Ka Shing, et al.
Publicado: (2020)

Budd-Chiari Syndrome: An Unusual Complication of AL Amyloidosis
por: Tiryaki, Tarık Onur, et al.
Publicado: (2020)

Rapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection
por: Hindilerden, Fehmi, et al.
Publicado: (2021)

The allele burden of JAK2 V617F can aid in differential diagnosis of Philadelphia Chromosome-Negative Myeloproliferative Neoplasm
por: Park, Sang Hyuk, et al.
Publicado: (2013)

Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin’s Lymphoma
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2021)

Comprehensive mastocytosis data analysis from a single center
por: Tiryaki, Tarık Onur, et al.
Publicado: (2023)

A Case with Hepatic Involvement Mimicking Metastatic Disease in Multiple Myeloma
por: Erciyestepe, Mert, et al.
Publicado: (2020)

Immune Thrombocytopenia in a Very Elderly Patient With Covid-19
por: Hindilerden, Fehmi, et al.
Publicado: (2020)

Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case
por: Hindilerden, Fehmi, et al.
Publicado: (2020)

A misleading presentation of T cell/histiocyte rich B-cell lymphoma mimicking osteomyelitis
por: Özpolat, Tahsin, et al.
Publicado: (2018)

Severe Autoimmune Hemolytic Anemia in COVID-19 İnfection, Safely Treated with Steroids
por: Hindilerden, Fehmi, et al.
Publicado: (2020)

JAK2V617F Allele Burden Measurement in Peripheral Blood of Iranian Patients with Myeloproliferative Neoplasms and Effect of Hydroxyurea on JAK2V617F Allele Burden
por: Ferdowsi, Shirin, et al.
Publicado: (2016)

A Rare Cause of Unexplained Refractory Iron Deficiency Anemia: Unicentric Plasma-Cell Type Castleman’s Disease
por: Kalayoğlu Beşışık, Sevgi, et al.
Publicado: (2016)

Allogeneic Hematopoietic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia: Results from a Single Center, 1993-2011
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2017)

The co-presence of deletion 7q, 20q and inversion 16 in therapy-related acute myeloid leukemia developed secondary to treatment of breast cancer with cyclophosphamide, doxorubicin, and radiotherapy: a case report
por: Yonal, Ipek, et al.
Publicado: (2012)

Evaluation of the JAK2V617F Mutational Burden in Patients with Philadelphia Chromosome Negative Myeloproliferative Neoplasms: A Single-center Experience
por: Popova-Labachevska, M, et al.
Publicado: (2019)

Characterization and Prognosis Significance of JAK2 (V617F), MPL, and CALR Mutations in Philadelphia-Negative Myeloproliferative Neoplasms
por: Singdong, Roongrudee, et al.
Publicado: (2016)

Plasmacytoma of the Nasolacrimal Duct Simulating Dacryocystitis: An Uncommon Presentation for Extramedullary Relapse of Multiple Myeloma
por: Kalayoglu-Besisik, Sevgi, et al.
Publicado: (2012)

Allelic Expression Imbalance of JAK2 V617F Mutation in BCR-ABL Negative Myeloproliferative Neoplasms
por: Kim, Hye-Ran, et al.
Publicado: (2013)

The JAK2(V617F) mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burden
por: Orbell, Lai Yee, et al.
Publicado: (2023)

Low JAK2 V617F Allele Burden in Ph-Negative Chronic Myeloproliferative Neoplasms Is Associated with Additional CALR or MPL Gene Mutations
por: Makarik, Tatiana V., et al.
Publicado: (2021)

The Association Between JAK2V617F Mutation and Bone Marrow Fibrosis at Diagnosis in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms
por: Arı, M. Cem, et al.
Publicado: (2012)

Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in JAK2V617F, CALR, and MPL
por: Wang, Yan, et al.
Publicado: (2023)

Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors
por: Helbig, Grzegorz
Publicado: (2018)

Gender and Vascular Complications in the JAK2 V617F-Positive Myeloproliferative Neoplasms
por: Stein, Brady L., et al.
Publicado: (2011)

Jak2V617F myeloproliferative neoplasm stem cells and interferon-alpha
por: Lane, Steven W., et al.
Publicado: (2013)

Detection of JAK2 V617F mutation increases the diagnosis of myeloproliferative neoplasms
por: ZHANG, SHU-PENG, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_30eq0cede3d7ln5nfe6a1jdgm9